<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="3296">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on October 07, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04374643</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL20_0197</org_study_id>
    <nct_id>NCT04374643</nct_id>
  </id_info>
  <brief_title>Descriptive Study of the PSYchological Impact of CONFinement Measures in the General Population</brief_title>
  <acronym>PsyConfPop</acronym>
  <official_title>Descriptive Study of the PSYchological Impact of CONFinement Measures in the General Population : PsyConfPop</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Quarantine is an unpleasant experience : separation from loved ones, loss of freedom,
      uncertainty about infection status, boredom. It may lead to negative mental health
      consequences and thus the emergence of anxiety and depressive symptoms.

      From March 17th, 2020 to May 11th 2002, the French government has implemented national
      containment measures due to the Covid-19 epidemic.

      Although there are data on the psychological impact and experience of quarantine measures in
      people who have been infected or suspected of being carriers of certain pathogens (e.g.
      Ebola), there are no data on such impact in the French population and quarantines lasting
      longer than 21 days. Investigators therefore propose to conduct a human and social sciences
      study in order to better understand the current situation
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The main objective is to describe the psychological state during confinement (and the impact
      of the confinement) in a sample of the French general population.

      Secondary objectives :

        -  to assess the evolution of psychological health between the period of confinement and
           post-confinement.

        -  to identify clinical factors modulating psychological state during confinement

      It is expected to highlight :

        -  a link between the intensity of anxiety symptoms and the number/quality of social
           contacts

        -  a reduction of anxiety and depression symptoms in the post-confinement period.

        -  higher consumption of drugs during the confinement period

      Self-questionnaires (Google form format) are sent by mailing lists or social networks to
      participants in order to complete the assessment of psychological state. A unique identifier
      is sent in a separate email. These assessments are performed at least once during the
      confinement period. It is planned to repeat them when the confinement is lifted: 15 days, 3
      and 6 months after the lifting of the confinement because of the risk of developing
      anxiodepressive symptoms, in particular post-traumatic stressors.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 1, 2020</start_date>
  <completion_date type="Anticipated">November 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">July 30, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Depressive Symptomatology</measure>
    <time_frame>during confinement</time_frame>
    <description>depressive symptomatology with Patient Health Questionnaire : PHQ-9 scale (PHQ 9 higher score, more depressive -&gt; min : 0 max : 27)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Depressive Symptomatology</measure>
    <time_frame>post-confinement : 15 days, 3 months, 6 months</time_frame>
    <description>depressive symptomatology with Patient Health Questionnaire : PHQ-9 scale (PHQ 9 higher score, more depressive -&gt; min : 0 max : 27)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Psychological pain</measure>
    <time_frame>during confinement</time_frame>
    <description>Psychological pain : likert scale (higher score, more psychological pain-&gt; min : 0 max : 10)</description>
  </other_outcome>
  <other_outcome>
    <measure>sleep</measure>
    <time_frame>during confinement</time_frame>
    <description>quality of sleep assessed with Insomnia Seveity Index (ISI Insomnia Severity Scale ; higher score, more insomnia -&gt; min : 0 max : 28)</description>
  </other_outcome>
  <other_outcome>
    <measure>sleep</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>quality of sleep assessed with Insomnia Seveity Index (ISI Insomnia Severity Scale ; higher score, more insomnia -&gt; min : 0 max : 28)</description>
  </other_outcome>
  <other_outcome>
    <measure>anxiety</measure>
    <time_frame>during confinement</time_frame>
    <description>anxiety intensity assessed by Generalized Anxieety Disorder (GAD 7 Generalized Anxiety Disorder higher score, more anxious -&gt; min : 0 max : 21)</description>
  </other_outcome>
  <other_outcome>
    <measure>anxiety</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>anxiety intensity assessed by Generalized Anxieety Disorder (GAD 7 Generalized Anxiety Disorder higher score, more anxious -&gt; min : 0 max : 21)</description>
  </other_outcome>
  <other_outcome>
    <measure>psychological pain</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>psychological pain : likert scale (higher score, more psychological pain-&gt; min : 0 max : 10)</description>
  </other_outcome>
  <other_outcome>
    <measure>physical pain</measure>
    <time_frame>during confinement</time_frame>
    <description>psychological pain : likert scale (higher score, more psychological pain-&gt; min : 0 max : 10)</description>
  </other_outcome>
  <other_outcome>
    <measure>physical pain</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>psychological pain : likert scale higher score, more psychological pain-&gt; min : 0 max : 10)</description>
  </other_outcome>
  <other_outcome>
    <measure>anger</measure>
    <time_frame>during confinement</time_frame>
    <description>staxi state scale (STAXI ; State and Trait Anger Expression Inventory : higher score, more anger -&gt; min : 0 max : 50)</description>
  </other_outcome>
  <other_outcome>
    <measure>anger</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>staxi state scale (STAXI ; State and Trait Anger Expression Inventory : higher score, more anger -&gt; min : 0 max : 50)</description>
  </other_outcome>
  <other_outcome>
    <measure>Stressful Event Impact</measure>
    <time_frame>during confinement</time_frame>
    <description>Assessed by the Stressful Event Impact Scale - Horowitz (HOROWITZ higher score, more traumatizes -&gt; min : 0 max : 45)
)</description>
  </other_outcome>
  <other_outcome>
    <measure>Stressful Event Impact</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>Assessed by the Stressful Event Impact Scale - Horowitz (HOROWITZ higher score, more traumatizes -&gt; min : 0 max : 45)</description>
  </other_outcome>
  <other_outcome>
    <measure>Use of psychotropic drugs</measure>
    <time_frame>during confinement</time_frame>
    <description>Number of patients declaring an increase of psychotropic drug use</description>
  </other_outcome>
  <other_outcome>
    <measure>Use of psychotropic drugs</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>Number of patients declaring an increase of psychotropic drug use</description>
  </other_outcome>
  <other_outcome>
    <measure>Tobacco consumption</measure>
    <time_frame>during confinement</time_frame>
    <description>Number of patients declaring an increase of tobacco consumption</description>
  </other_outcome>
  <other_outcome>
    <measure>Tobacco consumption</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>Number of patients declaring an increase of tobacco consumption</description>
  </other_outcome>
  <other_outcome>
    <measure>alcohol consumption</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>Number of patients declaring an increase of alcohol consumption</description>
  </other_outcome>
  <other_outcome>
    <measure>alcohol consumption</measure>
    <time_frame>confinement</time_frame>
    <description>Number of patients declaring an increase of alcohol consumption</description>
  </other_outcome>
  <other_outcome>
    <measure>Illicit substances consumption</measure>
    <time_frame>confinement</time_frame>
    <description>Number of patients declaring an increase of illicit substances consumption</description>
  </other_outcome>
  <other_outcome>
    <measure>Illicit substances consumption</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>Number of patients declaring an increase of illicit substances consumption</description>
  </other_outcome>
  <other_outcome>
    <measure>orientation of life</measure>
    <time_frame>confinement</time_frame>
    <description>Life Orinetation Test Revised (LOT-R questionnaire): higher score, more optimistic --&gt; min : 0 max : 24</description>
  </other_outcome>
  <other_outcome>
    <measure>orientation of life</measure>
    <time_frame>post-confinement (15 days, 3 months, 6 months)</time_frame>
    <description>Life Orinetation Test Revised (LOT-R questionnaire): higher score, more optimistic --&gt; min : 0 max : 24</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Depression</condition>
  <condition>COVID 19</condition>
  <arm_group>
    <arm_group_label>Confined patients</arm_group_label>
    <description>General population</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Slef questionnaires fulfilment</intervention_name>
    <description>Questionnaires to assess the psychological impact of confinement and its evolution over 6 months</description>
    <arm_group_label>Confined patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Adults who agree to participate by answering the questionnaires
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

        - age&gt; 18

        Exclusion criteria:

        - protective measure (curatorship, guardianship)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Emilie Olie, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Emilie Olie, MD PhD</last_name>
    <phone>+33 4 67 33 85 81</phone>
    <email>e-olie@chu-montpellier.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>University hospital</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Catherine Genty, MD</last_name>
      <phone>+33 4 67 99 61 45 75</phone>
      <email>c-genty@chu-montpellier.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2020</verification_date>
  <study_first_submitted>April 30, 2020</study_first_submitted>
  <study_first_submitted_qc>April 30, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">May 5, 2020</study_first_posted>
  <last_update_submitted>June 29, 2020</last_update_submitted>
  <last_update_submitted_qc>June 29, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 1, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Confinement</keyword>
  <keyword>Depression</keyword>
  <keyword>Post traumatic stress</keyword>
  <keyword>Adults</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Depression</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
    <ipd_description>NC</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

